Germany · 
Who invested in Definiens?
Definiens's investors include TVM Capital, Wellington Partners, Gilde Healthcare and Cipio Partners.
20132014
$13MVenture$20MVentureGermany · Venture startup
Who invested in Definiens
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Definiens and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$33Mraised across 2 rounds since 2012, from 2 sources
$13MVenture$20MVenture
- Latest round
- Venture, $20MJun 2014
- Step-upi
- 1.6×
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $13M Oct 2012
- Biggest round
- $20M Venture · Jun 2014
- Between rounds
- 21 months from the last two
The rounds
- Jun 2014Venture$20M2 new1 returning
From a historical funding record
- Oct 2012
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Exits
ExitBuyerPriceWhen
AcquiredMedImmune$150MNov 2014
AcquiredTrimbleundisclosedJun 2010
From historical deal records. Wrong? Tell us.
Everyone who backed them
Cipio PartnersVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Definiens
How much has Definiens raised?
Definiens has raised $33M across 2 rounds since 2012.
When did Definiens last raise?
Definiens's most recent round was a Venture of $20M in Jun 2014.
What was Definiens's biggest round?
Its most recent round, $20M in Jun 2014, is also its largest on record.
Who backed Definiens first?
Definiens's first round on record, in Oct 2012, was backed by TVM Capital and Gilde Healthcare.
What stage is Definiens at?
Definiens's latest named round is a Venture, in Jun 2014.
Where is Definiens based?
Definiens is based in Germany.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.